Search

Your search keyword '"Enterovirus pathogenicity"' showing total 481 results

Search Constraints

Start Over You searched for: Descriptor "Enterovirus pathogenicity" Remove constraint Descriptor: "Enterovirus pathogenicity" Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years
481 results on '"Enterovirus pathogenicity"'

Search Results

1. Extracellular vesicles in the pathogenesis of neurotropic viruses.

2. Analysis of miRNAs involved in mouse brain injury upon Coxsackievirus A6 infection.

3. Coxsackievirus A10 impairs nail regeneration and induces onychomadesis by mimicking DKK1 to attenuate Wnt signaling.

4. NLRP3-dependent pyroptosis exacerbates coxsackievirus A16 and coxsackievirus A10-induced inflammatory response and viral replication in SH-SY5Y cells.

5. Global landscape of coxsackieviruses in human health.

6. Pathogenicity and landscape of differential gene expression in mice orally infected with clinical coxsackievirus A6 (CA6).

7. Effects of glycine 64 substitutions in RNA-dependent RNA polymerase on ribavirin sensitivity and pathogenicity of coxsackievirus A6.

8. VP2 residue N142 of coxsackievirus A10 is critical for the interaction with KREMEN1 receptor and neutralizing antibodies and the pathogenicity in mice.

9. The importance of enterovirus surveillance in a post-polio world.

10. Viral determinants that drive Enterovirus-A71 fitness and virulence.

11. Coxsackievirus A2 Leads to Heart Injury in a Neonatal Mouse Model.

12. Viral and Prion Infections Associated with Central Nervous System Syndromes in Brazil.

13. Enterovirus-A71 Rhombencephalitis Outbreak in Catalonia: Characteristics, Management and Outcome.

14. TRIM7 inhibits enterovirus replication and promotes emergence of a viral variant with increased pathogenicity.

15. Clinical and laboratory detection of nonpolio enteroviruses among different age groups of aseptic meningitis patients in Alexandria, Egypt.

16. Review of infective dose, routes of transmission and outcome of COVID-19 caused by the SARS-COV-2: comparison with other respiratory viruses.

17. Essential Role of Non-Coding RNAs in Enterovirus Infection: From Basic Mechanisms to Clinical Prospects.

18. Prevalence of recessive infection of pathogens of hand, foot, and mouth disease in healthy people in China: A meta-analysis.

19. An epidemiological surveillance of hand foot and mouth disease in paediatric patients and in community: A Singapore retrospective cohort study, 2013-2018.

20. Enterovirus Infections Are Associated With the Development of Celiac Disease in a Birth Cohort Study.

21. Return of the Neurotropic Enteroviruses: Co-Opting Cellular Pathways for Infection.

22. Induction of the Coxsackievirus and Adenovirus Receptor in Macrophages During the Formation of Atherosclerotic Plaques.

23. Rational design of highly potent broad-spectrum enterovirus inhibitors targeting the nonstructural protein 2C.

24. Stimulator of interferon genes (STING) is an essential proviral host factor for human rhinovirus species A and C.

25. Genetic impact of CDHR3 on the adult onset of asthma and COPD.

26. Search for viral agents in cerebrospinal fluid in patients with multiple sclerosis using real-time PCR and metagenomics.

27. Coinfection in SARS-CoV-2 infected patients: Where are influenza virus and rhinovirus/enterovirus?

28. Peripheral Facial Nerve Palsy in Children With Enterovirus Infection.

29. Defining the proteolytic landscape during enterovirus infection.

30. Muscle destruction caused by coxsackievirus A10 in gerbils: Construction of a novel animal model for antiviral evaluation.

31. Rac1-dependent endocytosis and Rab5-dependent intracellular trafficking are required by Enterovirus A71 and Coxsackievirus A10 to establish infections.

32. Development of broad-spectrum enterovirus antivirals based on quinoline scaffold.

33. High correlation between human rhinovirus type C and children with asthma exacerbations in Taiwan.

34. A real-time polymerase chain reaction-based approach for qualitative estimation of viral RNA in organ tissues of coxsackievirus A-16-infected neonatal mice.

35. Epidemiological and aetiological characteristics of hand, foot, and mouth disease in Sichuan Province, China, 2011-2017.

36. Assessment of Thymic Output Dynamics After in utero Infection of Mice With Coxsackievirus B4.

37. Development of a reverse transcription loop-mediated isothermal amplification assay (RT-LAMP) that detects enteroviruses by targeting the highly conserved 5'-UTR region.

38. Rhinovirus C Is Associated With Severe Wheezing and Febrile Respiratory Illness in Young Children.

39. Enterovirus A71 capsid protein VP1 increases blood-brain barrier permeability and virus receptor vimentin on the brain endothelial cells.

40. Murine experimental models for studying the pathogenesis of coxsackieviruses.

41. Enterovirus pathogenesis requires the host methyltransferase SETD3.

42. Enteroviral infection in neonates.

43. Prospective virome analyses in young children at increased genetic risk for type 1 diabetes.

44. Exosomal MicroRNA-155 Inhibits Enterovirus A71 Infection by Targeting PICALM.

45. Related Enteric Viruses Have Different Requirements for Host Microbiota in Mice.

46. Nasal Cytokine Profiles of Patients Hospitalised with Respiratory Wheeze Associated with Rhinovirus C.

47. Pan-viral serology implicates enteroviruses in acute flaccid myelitis.

48. Pathological and molecular studies on Coxsackie virus A-16 isolated from hand, foot, and mouth disease cases in India: Approach using neonatal mouse model.

49. Anterior cingulate cortex involvement in non-paraneoplastic limbic encephalitis.

50. Comparative analysis of putative novel microRNA expression profiles induced by enterovirus 71 and coxsackievirus A16 infections in human umbilical vein endothelial cells using high-throughput sequencing.

Catalog

Books, media, physical & digital resources